{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:00Z","timestamp":1791920100463,"version":"4.3.4"},"reference-count":156,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jceh.2022.04.021","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T22:14:09Z","timestamp":1652480049000},"page":"1150-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Overview of Complications in Cirrhosis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2961-4148","authenticated-orcid":false,"given":"Madhumita","family":"Premkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-1540","authenticated-orcid":false,"given":"Anil C.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.04.021_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0973-6883(11)60127-8","article-title":"Pathophysiology of portal hypertension and its clinical links","volume":"1","author":"Seo","year":"2011","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","article-title":"The global impact of hepatic fibrosis and end-stage liver disease","volume":"12","author":"Lim","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.04.021_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3350\/cmh.2020.0068","article-title":"Alcohol associated liver cirrhotics have higher mortality after index hospitalization: long-term data of 5,138 patients","volume":"27","author":"Jain","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","article-title":"The epidemiology of cirrhosis in the United States: a population-based study","volume":"49","author":"Scaglione","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib7","first-page":"801","article-title":"Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption","volume":"72","author":"Singh","year":"2000","journal-title":"Hum Biol"},{"key":"10.1016\/j.jceh.2022.04.021_bib8","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.3748\/wjg.v20.i23.7217","article-title":"Influence of unrecorded alcohol consumption on liver cirrhosis mortality","volume":"20","author":"Lachenmeier","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5009\/gnl14363","article-title":"Complications requiring hospital admission and causes of in-hospital death overtime in alcoholic and nonalcoholic cirrhosis patients","volume":"10","author":"Kim","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2022.04.021_bib10","doi-asserted-by":"crossref","first-page":"e6163","DOI":"10.1097\/MD.0000000000006163","article-title":"Disease spectrum of alcoholic liver disease in Beijing 302 hospital from 2002 to 2013: a large tertiary referral hospital experience from 7422 patients","volume":"96","author":"Huang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jceh.2022.04.021_bib11","doi-asserted-by":"crossref","first-page":"e0187033","DOI":"10.1371\/journal.pone.0187033","article-title":"Etiology and mode of presentation of chronic liver diseases in India: a multi centric study","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.04.021_bib12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2019.07.006","article-title":"Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting","volume":"71","author":"Dhiman","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib13","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","article-title":"Cirrhosis and its complications: evidence-based treatment","volume":"20","author":"Nusrat","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0973-6883(11)60233-8","article-title":"Predicting mortality across a broad spectrum of liver disease-an assessment of model for end-stage liver disease (MELD), Child-Turcotte-Pugh (CTP), and creatinine-modified CTP scores","volume":"1","author":"Chawla","year":"2011","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.14309\/ajg.0000000000000653","article-title":"Clinical decompensation and outcomes in patients with compensated cirrhosis and a hepatic venous pressure gradient \u226520 mm Hg","volume":"115","author":"Jindal","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cld.978","article-title":"Hepatitis C virus elimination by 2030: conquering mount improbable","volume":"16","author":"Dhiman","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jceh.2022.04.021_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijid.2020.08.084","article-title":"Hepatitis-B virus infection in India: findings from a nationally representative serosurvey, 2017-18","volume":"100","author":"Murhekar","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jceh.2022.04.021_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/vaccines9040374","article-title":"Implications of birth-dose vaccination against hepatitis B virus in Southeast Asia","volume":"9","author":"Akbar","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jceh.2022.04.021_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jceh.2021.08.023","article-title":"Should we treat immune tolerant chronic hepatitis B? Lessons from Asia","volume":"12","author":"Premkumar","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.jceh.2022.04.021_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11938-019-00240-7","article-title":"Hepatitis C elimination: a public health perspective","volume":"17","author":"Dhiman","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1258\/td.2010.090463","article-title":"Prevalence of tuberculosis in patients with cirrhosis of liver in western India","volume":"40","author":"Baijal","year":"2010","journal-title":"Trop Doct"},{"issue":"2","key":"10.1016\/j.jceh.2022.04.021_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/gut.19.6.549","article-title":"Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid","volume":"19","author":"Reynolds","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.04.021_bib25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5009\/gnl.2012.6.3.355","article-title":"Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis","volume":"6","author":"Gu","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2022.04.021_bib27","first-page":"50","article-title":"Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites","volume":"27","author":"Zhu","year":"2013","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.jceh.2022.04.021_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jceh.2014.08.007","article-title":"Role of human albumin in the management of complications of liver cirrhosis","volume":"4","author":"Bernardi","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib29","first-page":"42","article-title":"Pathophysiology and prevention of paracentesis-induced circulatory dysfunction: a concise review","volume":"8","author":"Kulkarni","year":"2020","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2011.04.027","article-title":"Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17474124.2018.1555469","article-title":"An update on the pathogenesis and clinical management of cirrhosis with refractory ascites","volume":"13","author":"Neong","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/1756283X16684688","article-title":"Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites","volume":"10","author":"Stirnimann","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/liv.13074","article-title":"Response to Treatment of spontaneous bacterial peritonitis: beyond the current international guidelines","volume":"36","author":"Jindal","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.04.021_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5114\/ceh.2019.88774","article-title":"Clinical audit to determine efficacy of daily infusion of low dose of 20% albumin in combination with antibiotics in patients with spontaneous bacterial peritonitis","volume":"5","author":"Sanglodkar","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12664-020-01040-z","article-title":"Predictors of immediate and short-term mortality in spontaneous bacterial peritonitis","volume":"39","author":"Sanglodkar","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12072-020-10025-1","article-title":"Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis","volume":"14","author":"Soni","year":"2020","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.jceh.2022.04.021_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jceh.2021.10.145","article-title":"Impact of hyponatremia on morbidity, mortality, and resource utilization in portal hypertensive ascites: a nationwide analysis","volume":"12","author":"Thuluvath","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2022.04.021_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jceh.2021.09.008","article-title":"Clinical implications, evaluation, and management of hyponatremia in cirrhosis","volume":"12","author":"Praharaj","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jgh3.12166","article-title":"Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography","volume":"3","author":"Premkumar","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2022.04.021_bib41","first-page":"49","article-title":"Efficacy and safety of oral Tolvaptan therapy in hospitalized cirrhotic patients with hyponatremia","volume":"66","author":"Garg","year":"2018","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2022.04.021_bib42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jceh.2020.08.010","article-title":"Recurrent and treatment-unresponsive spontaneous bacterial peritonitis worsens survival in decompensated liver cirrhosis","volume":"11","author":"Falleti","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib44","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.04.021_bib45","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1136\/gutjnl-2017-314324","article-title":"Assessment of Sepsis-3 criteria, and quick SOFA in patients with cirrhosis and bacterial infections","volume":"67","author":"Piano","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.04.021_bib46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"European Foundation for the Study of Chronic Liver Failure (EF-Clif). Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2022.04.021_bib48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12664-014-0461-3","article-title":"A\u00a0multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver","volume":"33","author":"Baijal","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jceh.2017.05.003","article-title":"An insight into antibiotic resistance to bacterial infection in chronic liver disease","volume":"7","author":"Jain","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jgar.2018.12.025","article-title":"Dissemination, and characterisation of Escherichia coli producing extended-spectrum \u03b2-lactamases, AmpC \u03b2-lactamases and metallo-\u03b2-lactamases from livestock and poultry in Northeast India: a molecular surveillance approach","volume":"17","author":"Tewari","year":"2019","journal-title":"J\u00a0Glob Antimicrob Resist"},{"issue":"Pt 1","key":"10.1016\/j.jceh.2022.04.021_bib51","doi-asserted-by":"crossref","first-page":"113143","DOI":"10.1016\/j.envpol.2019.113143","article-title":"The threat of carbapenem-resistant bacteria in the environment: evidence of widespread contamination of reservoirs at a global scale","volume":"255","author":"Mills","year":"2019","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jceh.2022.04.021_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12866-017-1012-8","article-title":"Structure, genetics and worldwide spread of New Delhi metallo-\u03b2-lactamase (NDM): a threat to public health","volume":"17","author":"Khan","year":"2017","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jceh.2022.04.021_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1574887114666181204102516","article-title":"Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: nosocomial versus community-acquired infections and the role of fungi","volume":"14","author":"Maraolo","year":"2019","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.jceh.2022.04.021_bib54","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.3748\/wjg.v26.i47.7485","article-title":"Invasive fungal infection before and after liver transplantation","volume":"26","author":"Ferrarese","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib55","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4254\/wjh.v11.i7.596","article-title":"Spontaneous fungal peritonitis: micro-organisms, management, and mortality in liver cirrhosis-A systematic review","volume":"11","author":"Tariq","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1017\/ice.2020.368","article-title":"Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge","volume":"42","author":"Nori","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jceh.2022.04.021_bib57","doi-asserted-by":"crossref","first-page":"myab064","DOI":"10.1093\/mmy\/myab064","article-title":"Aspergillosis: emerging risk groups in critically ill patients","volume":"60","author":"Kluge","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.jceh.2022.04.021_bib58","doi-asserted-by":"crossref","first-page":"e247399","DOI":"10.1136\/bcr-2021-247399","article-title":"Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure","volume":"15","author":"Menezes","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jceh.2022.04.021_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.04.021_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition, and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib61","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.04.021_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib63","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"ANSWER Study Investigators. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.04.021_bib64","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis","volume":"18","author":"Fernandez","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jceh.2015.08.003","article-title":"Randomized controlled trial comparing the efficacy of terlipressin and albumin with a combination of concurrent dopamine, furosemide, and albumin in hepatorenal syndrome","volume":"5","author":"Srivastava","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib66","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1111\/liv.14703","article-title":"Terlipressin has stood the test of time: clinical overview in 2020 and future perspectives","volume":"40","author":"Kulkarni","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.04.021_bib67","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib68","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1572-0241.2000.01775.x","article-title":"Natural history of cirrhotic patients with small esophageal varices: a prospective study","volume":"95","author":"Zoli","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib70","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib71","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/hep.29363","article-title":"Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease","volume":"66","author":"Augustin","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12664-018-0887-0","article-title":"Improving outcomes with pharmacotherapy to treat acute esophageal variceal bleeding","volume":"37","author":"Eapen","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib73","doi-asserted-by":"crossref","first-page":"356919","DOI":"10.4061\/2011\/356919","article-title":"Improved survival with the patients with variceal bleed","volume":"2011","author":"Sharma","year":"2011","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jgh3.12449","article-title":"Liver stiffness assessment as an alternative to hepatic venous pressure gradient for predicting rebleed after acute variceal bleed: a proof-of-concept study","volume":"5","author":"Agarwal","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2022.04.021_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jceh.2013.01.002","article-title":"Gastric varices in cirrhosis versus extrahepatic portal venous obstruction and response to endoscopic N-Butyl-2-cyanoacrylate injection","volume":"3","author":"Sharma","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0973-6883(12)60088-7","article-title":"Gluing gastric varices in 2012: lessons learnt over 25 years","volume":"2","author":"Saraswat","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12664-018-0844-y","article-title":"Endoscopic ultrasound-guided coil, or glue injection in post-cyanoacrylate gastric variceal re-bleed","volume":"37","author":"Mukkada","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0973-6883(12)60083-8","article-title":"Endoscopic ultrasound (EUS) for esophageal and gastric varices: how can it improve the outcomes and reduce complications of glue injection","volume":"2","author":"Bhatia","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2022.04.021_bib80","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jceh.2021.08.030","article-title":"Management of refractory variceal bleed in cirrhosis","volume":"12","author":"Rodge","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib81","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1572-0241.2005.40468.x","article-title":"Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding","volume":"100","author":"Sarin","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib82","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jceh.2017.09.003","article-title":"Can non-selective beta-blockers (NSBBs) prevent enlargement of small esophageal varices in patients with cirrhosis? A meta-analysis","volume":"7","author":"Kumar","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib83","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","article-title":"Carvedilol combined with ivabradine improves left ventricular diastolic dysfunction, clinical progression, and survival in cirrhosis","volume":"54","author":"Premkumar","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib84","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jceh.2020.08.009","article-title":"Long-term outcomes with carvedilol versus propranolol in patients with index variceal bleed: 6-year follow-up study","volume":"11","author":"Sharma","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib85","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.04.021_bib86","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cld.976","article-title":"Current concepts in coagulation profile in cirrhosis and acute-on-chronic liver failure","volume":"16","author":"Premkumar","year":"2020","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.jceh.2022.04.021_bib87","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cgh.2019.04.057","article-title":"Heparin-like effect associated with risk of bleeding, sepsis, and death in patients with severe alcohol-associated hepatitis","volume":"18","author":"Premkumar","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jceh.2022.04.021_bib88","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jceh.2021.11.003","article-title":"Portal vein thrombosis in cirrhosis","volume":"12","author":"Shukla","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib89","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jceh.2021.05.001","article-title":"Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure","volume":"12","author":"Premkumar","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib90","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A\u00a0global view of hepatocellular carcinoma: trends, risk, prevention, and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib91","first-page":"274","article-title":"Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from tertiary care center in northern India","volume":"26","author":"Paul","year":"2007","journal-title":"Indian J Gastroenterol"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2022.04.021_bib92","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jceh.2014.05.013","article-title":"Epidemiology of hepatocellular carcinoma in India","volume":"4","author":"Acharya","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2022.04.021_bib94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jceh.2019.09.007","article-title":"INASL Taskforce on Hepatocellular Carcinoma. 2019 update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: the Puri II recommendations","volume":"10","author":"Kumar","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib95","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib96","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ejso.2019.09.009","article-title":"Real-world role of performance status in surgical resection for hepatocellular carcinoma: a multicenter study","volume":"45","author":"Wu","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jceh.2022.04.021_bib97","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/SLA.0000000000003014","article-title":"Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korea-Japan multicenter study","volume":"271","author":"Kim","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2022.04.021_bib98","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.29225","article-title":"Liver Cancer Study Group of Japan. Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey","volume":"66","author":"Kokudo","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib99","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jceh.2018.07.001","article-title":"Current diagnosis and classification of hepatic encephalopathy","volume":"8","author":"Amodio","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2022.04.021_bib100","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jceh.2014.06.005","article-title":"Diagnosis of minimal hepatic encephalopathy","volume":"5","author":"Weissenborn","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib101","article-title":"Combined PEG3350 plus lactulose results in early resolution of hepatic encephalopathy and improved 28-day survival in acute-on-chronic liver failure","author":"Ahmed","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2022.04.021_bib102","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jceh.2014.06.004","article-title":"Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation","volume":"5","author":"Aldridge","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib103","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000343","article-title":"Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis","volume":"115","author":"Haj","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib104","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.29410","article-title":"L-ornithine L-aspartate in bouts of overt hepatic encephalopathy","volume":"67","author":"Sidhu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib105","article-title":"L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: a double-blind randomized controlled trial","author":"Jain","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib106","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.04.021_bib107","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A\u00a0randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib108","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2022.04.021_bib109","first-page":"CD001939","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"5","author":"Gluud","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.04.021_bib110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic cardiomyopathy","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jceh.2022.04.021_bib111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jceh.2018.08.008","article-title":"Left ventricular diastolic dysfunction is associated with renal dysfunction, poor survival and low health related quality of life in cirrhosis","volume":"9","author":"Premkumar","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib112","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Cirrhotic cardiomyopathy consortium. Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib113","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.26745","article-title":"Pulmonary complications in chronic liver disease","volume":"59","author":"Machicao","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.021_bib114","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3748\/wjg.v20.i10.2586","article-title":"Cirrhosis and hepatopulmonary syndrome","volume":"20","author":"Tumgor","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2014.01.003","article-title":"Hepatopulmonary syndrome","volume":"18","author":"Koch","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.04.021_bib116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0973-6883(11)60167-9","article-title":"30 excellent outcome of living donor liver transplantation in patients with hepatopulmonary syndrome-a single center experience","volume":"1","author":"Saigal","year":"2011","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib117","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jceh.2017.11.001","article-title":"Nutrition and muscle in cirrhosis","volume":"7","author":"Anand","year":"2017","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib118","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jceh.2019.12.003","article-title":"Sarcopenia in cirrhosis: fallout on liver transplantation","volume":"10","author":"Kumar","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.jceh.2022.04.021_bib119","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jceh.2021.10.013","article-title":"Physical activity patterns in frail and nonfrail patients with end-stage liver disease","volume":"12","author":"Handelzalts","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jceh.2016.02.001","article-title":"Liver transplantation for alcohol-related liver disease","volume":"6","author":"Choudhary","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2022.04.021_bib121","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.jceh.2014.01.002","article-title":"Role of liver transplantation for hepatocellular carcinoma","volume":"4","author":"Kumaran","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib122","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jceh.2020.04.015","article-title":"Functional status at liver transplant waitlisting correlates with greater odds of encephalopathy, ascites, and spontaneous bacterial peritonitis","volume":"10","author":"McCabe","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib123","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2019.06.006","article-title":"Poor performance status predicts mortality after living donor liver transplantation","volume":"10","author":"Choudhary","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib124","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jceh.2020.07.011","article-title":"Ethnicity and insurance-specific disparities in the model for end-stage liver disease score at time of liver transplant waitlist registration and its impact on mortality","volume":"11","author":"Robinson","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2020.05.023","article-title":"An international multicenter study of protocols for liver transplantation during a pandemic: a case for quadripartite equipoise","volume":"73","author":"Chew","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s41649-019-00083-5","article-title":"Ayushman Bharat National Health Protection Scheme: an ethical analysis","volume":"11","author":"Gopichandran","year":"2019","journal-title":"Asian Bioeth Rev"},{"key":"10.1016\/j.jceh.2022.04.021_bib127","first-page":"61","article-title":"Live donor liver transplantation: is this really the way liver transplantation should be developed in India?","volume":"17","author":"Silva","year":"2004","journal-title":"Natl Med J India"},{"key":"10.1016\/j.jceh.2022.04.021_bib128","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jceh.2020.12.002","article-title":"Midodrine improves the tolerability of diuretics in patients with acute-on-chronic liver failure-A pilot study","volume":"11","author":"Kulkarni","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib129","first-page":"CD004889","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","volume":"2006","author":"Saab","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.04.021_bib130","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.14309\/ajg.0000000000001272","article-title":"Effect of vitamin D supplementation on vitamin D level and bone mineral density in patients with cirrhosis: a randomized clinical trial","volume":"116","author":"Grover","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib131","first-page":"CD011564","article-title":"Vitamin D supplementation for chronic liver diseases in adults","volume":"8","author":"Bjelakovic","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2022.04.021_bib132","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2015","volume":"51","author":"Fukui","year":"2016","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib133","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/gut.36.1.110","article-title":"Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake","volume":"36","author":"van de Verboeket Venne","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.04.021_bib134","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1475-2891-12-119","article-title":"Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C\u2013a randomized trial","volume":"12","author":"Rusu","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.jceh.2022.04.021_bib135","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/apt.13523","article-title":"Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis","volume":"43","author":"Kennedy","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.04.021_bib136","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cgh.2013.04.039","article-title":"Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis","volume":"11","author":"Bravi","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib137","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cgh.2017.04.039","article-title":"Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: a systematic review and meta-analysis","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib138","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","article-title":"Cirrhosis as new indication for statins","volume":"69","author":"Bosch","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.04.021_bib139","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/lt.25193","article-title":"Palliative care in end-stage liver disease: time to do better?","volume":"24","author":"Mazzarelli","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2022.04.021_bib140","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/imj.14348","article-title":"Palliative care in cirrhosis with decompensation","volume":"49","author":"Plunkett","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.jceh.2022.04.021_bib141","series-title":"Local Coverage Determination (LCD) for Hospice Determining Terminal Status (L33393)","year":"2021"},{"key":"10.1016\/j.jceh.2022.04.021_bib142","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jhep.2018.08.028","article-title":"Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals","volume":"69","author":"Low","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib143","first-page":"S122","article-title":"Dying with end\u00a0stage liver disease with cirrhosis: insights from SUPPORT. Study to understand prognoses and preferences for outcomes\u00a0and risks of treatment","volume":"48","author":"Roth","year":"2000","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jceh.2022.04.021_bib144","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cgh.2013.08.027","article-title":"Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management","volume":"12","author":"Poonja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12664-017-0773-1","article-title":"HRQOL using SF36 (generic specific) in liver cirrhosis","volume":"36","author":"Janani","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.021_bib146","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep4.1743","article-title":"Developing priorities for palliative care research in advanced liver disease: a multidisciplinary approach","volume":"5","author":"Patel","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2022.04.021_bib147","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jceh.2021.10.147","article-title":"Treatment of muscle cramps inpatients with cirrhosis of liver: A systematic review","volume":"12","author":"Kalia","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2022.04.021_bib148","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jceh.2021.08.028","article-title":"Fatigue in cirrhosis","volume":"12","author":"Bhandari","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib149","first-page":"385","article-title":"Long-term outcome of autologous hematopoietic stem cell infusion in cirrhosis: waning effect over time","volume":"8","author":"Sharma","year":"2020","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2022.04.021_bib150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jceh.2021.08.010","article-title":"Rifaximin vs. norfloxacin for spontaneous bacterial peritonitis prophylaxis: a randomized controlled trial","volume":"12","author":"Praharaj","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib151","doi-asserted-by":"crossref","first-page":"101675","DOI":"10.1016\/j.clinre.2021.101675","article-title":"Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis","volume":"45","author":"Kulkarni","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2022.04.021_bib152","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jceh.2021.09.021","article-title":"Sarcopenia is closely associated with frailty in decompensated cirrhosis","volume":"12","author":"Gnanadeepam","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib153","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jgh3.12359","article-title":"Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: a national multicenter study","volume":"4","author":"Camus","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2022.04.021_bib154","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3350\/cmh.2020.0194","article-title":"The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future","volume":"27","author":"Watanabe","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib155","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/jgh.12560","article-title":"Analgesia for the cirrhotic patient: a literature review and recommendations","volume":"29","author":"Dwyer","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.021_bib156","first-page":"27","article-title":"Intravenous patient-controlled fentanyl with and without transversus abdominis plane block in cirrhotic patients post liver resection","volume":"7","author":"Serag Eldin","year":"2014","journal-title":"Local Reg Anesth"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:04Z","timestamp":1760854084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322001293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":156,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0973688322001293"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.04.021","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of Complications in Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}